Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
57.9M
-
Shares change
-
+1.8M
-
Total reported value, excl. options
-
$626M
-
Value change
-
+$18.1M
-
Put/Call ratio
-
0.59
-
Number of buys
-
78
-
Number of sells
-
-60
-
Price
-
$10.82
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q2 2024
159 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q2 2024.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.9M shares
of 69M outstanding shares and own 83.96% of the company stock.
Largest 10 shareholders include BVF INC/IL (9.14M shares), Paradigm Biocapital Advisors LP (7.9M shares), Deep Track Capital, LP (4M shares), BlackRock Inc. (4M shares), Point72 Asset Management, L.P. (3.21M shares), Logos Global Management LP (3.21M shares), VANGUARD GROUP INC (2.74M shares), MPM BIOIMPACT LLC (2.65M shares), STATE STREET CORP (1.95M shares), and Vivo Capital, LLC (1.87M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.